Why Everything You Know Is Wrong

Alexander Green
by Alexander Green, Chief Investment Strategist, The Oxford Club

Turn on the news and you'll hear stories of crime, war, terrorism, disease, natural disasters, corruption, domestic violence, poverty, economic inequality, nuclear proliferation, environmental degradation and political dysfunction in Washington.

Polls show Americans believe the American dream is fading, our children face limited opportunities and the country - if not civilization itself - is decidedly on the wrong track.

Yet this dour perspective - one recycled 24/7 by the national media - is a gross distortion of the world we live in.

Four years ago, I set out to counter this narrative - to tell what Paul Harvey called "the rest of the story" - in my book titled An Embarrassment of Riches.

I can already hear some readers objecting, insisting that the problems above are quite real.

So let me give you an analogy...

Imagine that I show a roomful of college students a five-minute video I'd made of a former basketball player. In clip after clip, the player can't do anything right. He throws air balls, blows layups, misses rebounds, clanks free throws, double dribbles and steps out of bounds.

When the film is over, I tell my young audience, "The player's name is Michael Jordan. What do you think of him?"

No doubt most would say, "My God, he's terrible."

Everyone else - especially anyone over age 35 - would lose their minds.

Not because Michael Jordan never shot air balls or clanked free throws. (As a longtime NBA fan, I saw him do both many times.) But because the video - though made up entirely of real incidents - is a gross distortion of the man's abilities and career.

In short, I used real truths to create a false impression.

And the national media - through its prism of constant negativity - does the same thing to you and me every day.

Drip... drip... drip... drip... drip.

Yes, we live in a world with crime, war, poverty and other serious problems.

Yet the news media makes no attempt to paint a faithful depiction of the lives most of us lead.

War between nations, civil wars, terrorist incidents, violent crime, domestic violence, child abuse and even abortions are all down.

We in the West work shorter hours, have more purchasing power, enjoy goods and services in almost limitless supply, and have more leisure time than ever before.

The human life span has nearly doubled over the past hundred years.

Living standards are the highest they have ever been.

Literacy and education levels - even IQs - are at all-time highs.

Technology and medicine are revolutionizing and saving our lives.

All forms of pollution - with the exception of greenhouse gases - are in decline.

By almost every measure, our lives today are wealthy beyond measure. We are cultural heirs to an embarrassment of riches.

Yet - thanks in large part to continual, downbeat news coverage - most of us don't realize it.

The average person is like an unwitting lottery winner whose ticket is lost in some upstairs drawer.

The consequences of adopting a cynical but popular worldview are many, including depressed mood, missed investment opportunities... even a shortened life span.

For years now - both in my weekly columns and all four of my books - I have tried to counter this mindset.

And a few weeks ago, I gained a powerful ally: Steven Pinker.

Pinker is a Harvard psychologist, best-selling author and one of the world's most influential thinkers, according to Time magazine.

His new book, Enlightenment Now, is a tour de force.

Using objective data, evidence and reason - not to mention 75 mind-blowing graphs - he demolishes the cynical attitude that pervades today's public discourse by revealing how our lives are becoming not worse as many feel... but longer, healthier, safer, freer, less violent and more prosperous.

Not just here but - with the exception of a few unfortunate spots in the Middle East - around the globe.

The number and variety of ways the world is getting better will astonish you.

Americans today, for example, are 37 times less likely to be killed by lightning than in 1900.

How is that possible? Thank better weather forecasting, improved electrical engineering, greater safety awareness and - for those unfortunate enough to be struck - higher-quality emergency care.

Few books will literally change your perspective of the world. This one will.

Bill Gates - an avid reader as well as the world's second-richest man - calls it, "My new favorite book of all time."

Over the next few columns, I will unpack Pinker's thesis - one that dovetails with my own - and demonstrate how adopting a more evidence-based worldview won't just make you more upbeat and better informed...

It will make you a far more successful investor.

Good investing,


Thoughts on this article? Leave a comment below.

Another Possible Biotech Blockbuster?

As Alex alluded to above, one of the reasons we're actually better off now is because our healthcare is better than at any other time in history. Pharmaceutical companies big and small are constantly engaged in research and development to find new medicinal and technological solutions for pervasive medical problems.

That's why Alex added Intercept Pharmaceuticals (Nasdaq: ICPT) to his Insider Alert portfolio earlier this month. With insiders recently buying up a lot of the company's stock, he has reason to believe it's poised to rally back toward its 52-week high...

Today I have a new recommendation for you: Intercept Pharmaceuticals (Nasdaq: ICPT).

I began the year by forecasting that 2018 would be an excellent year for small cap pharmaceutical stocks.

Why? Because Big Pharma companies urgently need to refill their drug pipelines. And buying promising companies is cheaper than developing new therapies from scratch.

With this in mind, let's look at recent heavy insider buying in Intercept Pharmaceuticals.

Based in New York City, Intercept is a biotech company devoted to the development and commercialization of new therapeutics to treat progressive nonviral liver diseases.

Two years ago, the FDA granted accelerated approval to the company's lead product, Ocaliva, a treatment for primary biliary cholangitis, commonly known as biliary cirrhosis.

Ocaliva is also being evaluated as a treatment for a variety of other chronic liver diseases, including nonalcoholic steatohepatitis (NASH), primary sclerosing cholangitis and biliary atresia. (These are all in either Phase 2 or Phase 3 trials.)

The FDA has granted Ocaliva breakthrough therapy designation for the treatment of NASH with liver fibrosis.

A young company with a market cap of just over $2 billion, Intercept is not yet profitable.

Yet sales are taking off. Revenue is growing at a 173% rate year over year. And while it is too early to forecast positive earnings, sales should more than double again in 2019.

And if you look at what the insiders are doing, that forecast may prove conservative.

Earlier this month, CEO Mark Pruzanski and Director Daniel Bradbury each bought a half-million dollars' worth of the stock.

Another enthusiastic insider is Francesco Micheli, who is a beneficial owner. (That means he owns more than 10% of the outstanding shares and must file his purchases and sells with the SEC.)

Micheli, an Italian entrepreneur, is a co-founder and the CEO of Genextra, a successful private capital group specializing in biotechnology. Last week, he purchased 391,000 shares, an investment of more than $25 million.

The sheer size of these transactions indicates that these insiders - with their access to all sorts of material, nonpublic information about Intercept's future prospects - believe these shares are undervalued.

Indeed, the stock currently trades more than 60 points below its 52-week high.

That's partly because the company reported a 25% earnings miss for the December quarter. But I believe we will see positive sales and earnings surprises in the weeks ahead, starting with the next quarterly report the first week of May.

Insiders own 26.3% of the outstanding shares here. And the recent activity indicates there is plenty of upside ahead.

- Donna DiVenuto-Ball with Alexander Green

Live Twitter Feed